Axogen Inc Stock Earnings Per Share

AXGN Stock  USD 17.90  0.27  1.53%   
Axogen Inc fundamentals help investors to digest information that contributes to Axogen's financial success or failures. It also enables traders to predict the movement of Axogen Stock. The fundamental analysis module provides a way to measure Axogen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Axogen stock.
Short Long Term Debt TotalTotal Assets
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Axogen Inc Company Earnings Per Share Analysis

Axogen's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.

Earnings per Share

 = 

Earnings

Average Shares

More About Earnings Per Share | All Equity Analysis

Current Axogen Earnings Per Share

    
  (0.23) X  
Most of Axogen's fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Axogen Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Axogen Earnings Per Share Driver Correlations

Understanding the fundamental principles of building solid financial models for Axogen is extremely important. It helps to project a fair market value of Axogen Stock properly, considering its historical fundamentals such as Earnings Per Share. Since Axogen's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Axogen's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Axogen's interrelated accounts and indicators.
0.930.49-0.940.960.840.9-0.350.830.860.890.070.850.890.550.670.940.95-0.880.980.710.8
0.930.18-0.790.860.580.97-0.420.630.770.820.070.640.980.280.380.90.82-0.870.960.890.58
0.490.18-0.620.520.840.09-0.020.760.490.350.050.830.120.810.910.390.67-0.230.42-0.140.8
-0.94-0.79-0.62-0.97-0.92-0.750.2-0.91-0.92-0.92-0.01-0.91-0.74-0.63-0.78-0.9-0.930.84-0.87-0.48-0.87
0.960.860.52-0.970.860.82-0.30.890.940.920.090.880.810.510.690.910.92-0.90.910.560.85
0.840.580.84-0.920.860.55-0.160.910.780.760.060.950.520.830.950.740.88-0.660.750.260.91
0.90.970.09-0.750.820.55-0.340.530.690.850.070.540.960.30.340.870.74-0.870.920.920.48
-0.35-0.42-0.020.2-0.3-0.16-0.34-0.25-0.31-0.110.04-0.26-0.42-0.06-0.1-0.33-0.320.41-0.38-0.33-0.23
0.830.630.76-0.910.890.910.53-0.250.840.73-0.020.970.550.570.840.720.91-0.660.760.250.99
0.860.770.49-0.920.940.780.69-0.310.840.840.020.830.730.440.60.850.85-0.820.810.420.79
0.890.820.35-0.920.920.760.85-0.110.730.840.040.710.780.450.570.870.8-0.920.820.590.67
0.070.070.05-0.010.090.060.070.04-0.020.020.040.060.070.090.080.090.07-0.10.070.060.05
0.850.640.83-0.910.880.950.54-0.260.970.830.710.060.570.680.880.760.95-0.650.790.280.98
0.890.980.12-0.740.810.520.96-0.420.550.730.780.070.570.270.310.930.76-0.840.930.890.48
0.550.280.81-0.630.510.830.3-0.060.570.440.450.090.680.270.890.520.61-0.350.480.090.59
0.670.380.91-0.780.690.950.34-0.10.840.60.570.080.880.310.890.550.77-0.450.580.070.87
0.940.90.39-0.90.910.740.87-0.330.720.850.870.090.760.930.520.550.86-0.870.930.70.65
0.950.820.67-0.930.920.880.74-0.320.910.850.80.070.950.760.610.770.86-0.760.920.540.89
-0.88-0.87-0.230.84-0.9-0.66-0.870.41-0.66-0.82-0.92-0.1-0.65-0.84-0.35-0.45-0.87-0.76-0.83-0.67-0.6
0.980.960.42-0.870.910.750.92-0.380.760.810.820.070.790.930.480.580.930.92-0.830.80.73
0.710.89-0.14-0.480.560.260.92-0.330.250.420.590.060.280.890.090.070.70.54-0.670.80.21
0.80.580.8-0.870.850.910.48-0.230.990.790.670.050.980.480.590.870.650.89-0.60.730.21
Click cells to compare fundamentals
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
Competition

Axogen Common Stock Shares Outstanding

Common Stock Shares Outstanding

46.47 Million

At this time, Axogen's Common Stock Shares Outstanding is very stable compared to the past year.
According to the company disclosure, Axogen Inc has an Earnings Per Share of -0.23 times. This is 102.75% lower than that of the Health Care Equipment & Supplies sector and notably lower than that of the Health Care industry. The earnings per share for all United States stocks is 107.37% higher than that of the company.

Axogen Earnings Per Share Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Axogen's direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Axogen could also be used in its relative valuation, which is a method of valuing Axogen by comparing valuation metrics of similar companies.
-0.234.253.401.160.75100%
Axogen is currently under evaluation in earnings per share category among its peers.

Axogen ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Axogen's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Axogen's managers, analysts, and investors.
56.1%
Environmental
58.7%
Governance
Social

Axogen Fundamentals

Return On Equity-0.0999
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-120,000%-100,000%-80,000%-60,000%-40,000%-20,000%0%
Return On Asset-0.0103
Profit Margin(0.05) %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-1,500%-1,000%-500%
Operating Margin0.04 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-1,400%-1,200%-1,000%-800%-600%-400%-200%
Current Valuation816.98 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312,000%4,000%6,000%8,000%
Shares Outstanding44.34 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%
Shares Owned By Insiders5.49 %
Shares Owned By Institutions8.00 %
Number Of Shares Shorted1.85 M
Price To Earning(47.07) X
Price To Book7.52 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%5,000%10,000%15,000%20,000%
Price To Sales4.17 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%100%200%300%400%500%
Revenue187.34 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-311,000%2,000%3,000%4,000%
Gross Profit141.98 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-315,000%10,000%15,000%20,000%
EBITDA6.08 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-8,000%-6,000%-4,000%-2,000%0%2,000%
Net Income(9.96 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-6,000%-5,000%-4,000%-3,000%-2,000%-1,000%
Cash And Equivalents58.03 M
Cash Per Share1.37 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31100%200%300%400%500%600%700%
Total Debt68.69 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%2,000%4,000%6,000%8,000%10,000%12,000%
Debt To Equity0.71 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%50,000%100,000%150,000%
Current Ratio4.52 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%50%100%150%200%250%
Book Value Per Share2.35 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%-50%0%50%100%
Cash Flow From Operations4.54 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-3,000%-2,000%-1,000%0%
Short Ratio3.87 X
Earnings Per Share(0.23) X
Target Price25.71
Number Of Employees451
Beta1.02
Market Capitalization781.78 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312,000%4,000%6,000%8,000%
Total Asset203.73 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%2,000%2,500%3,000%
Retained Earnings(291.26 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-20,000%-15,000%-10,000%-5,000%
Working Capital68.61 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Current Asset35.05 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-311,000%2,000%3,000%4,000%5,000%6,000%
Current Liabilities3.71 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-311,000%2,000%3,000%4,000%
Net Asset203.73 M

About Axogen Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Axogen Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Axogen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Axogen Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with Axogen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Axogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axogen will appreciate offsetting losses from the drop in the long position's value.

Moving together with Axogen Stock

  0.66GH Guardant HealthPairCorr
  0.76LH LaboratoryPairCorr

Moving against Axogen Stock

  0.81EUDA EUDA Health HoldingsPairCorr
  0.66OM Outset MedicalPairCorr
  0.63VREX Varex Imaging CorpPairCorr
  0.58ESTA Establishment LabsPairCorr
  0.55EMBC Embecta CorpPairCorr
The ability to find closely correlated positions to Axogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Axogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Axogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Axogen Inc to buy it.
The correlation of Axogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Axogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Axogen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Axogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Axogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Axogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Axogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Axogen Inc Stock:
Check out Axogen Piotroski F Score and Axogen Altman Z Score analysis.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axogen. If investors know Axogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.23)
Revenue Per Share
4.233
Quarterly Revenue Growth
0.151
Return On Assets
(0.01)
Return On Equity
(0.1)
The market value of Axogen Inc is measured differently than its book value, which is the value of Axogen that is recorded on the company's balance sheet. Investors also form their own opinion of Axogen's value that differs from its market value or its book value, called intrinsic value, which is Axogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axogen's market value can be influenced by many factors that don't directly affect Axogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.